Additional work is needed to understand the impact of discrete microenvironments (e.g., tumor, TdLNs) on STAT3 signaling in CD103+ cDC1s as well as CD103+ cDC1-mediated T cell activation and recruitment. This evidence concerns the gene STAT3 and neoplasm.